首页> 美国卫生研究院文献>PLoS Clinical Trials >Systematic Analysis of the Gene Expression in the Livers of Nonalcoholic Steatohepatitis: Implications on Potential Biomarkers and Molecular Pathological Mechanism
【2h】

Systematic Analysis of the Gene Expression in the Livers of Nonalcoholic Steatohepatitis: Implications on Potential Biomarkers and Molecular Pathological Mechanism

机译:非酒精性脂肪性肝炎肝组织中基因表达的系统分析:对潜在生物标志物和分子病理机制的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD). The molecular pathological mechanism of NASH is poorly understood. Recently, high throughput data such as microarray data together with bioinformatics methods have become a powerful way to identify biomarkers and to investigate pathogenesis of diseases. Taking advantage of well characterized microarray datasets of NASH livers, we performed a systematic analysis of potential biomarkers and possible pathological mechanism of NASH from a bioinformatics perspective.CodeLink Human Whole Genome Bioarrays were analyzed to find differentially expressed genes (DEGs) between controls and NASH patients. Four methods were used to identify DEGs and the intersection of DEGs identified by these methods was subsequently used for both biomarker prediction and molecular pathological mechanism analysis. For biomarker prediction, rank aggregation was used to rank DEGs identified by all these methods according to their significance of different expression. Alcohol dehydrogenase 4 (ADH4) exhibited the highest rank suggesting the most significant differential expression between normal and disease condition. Together with the previous report demonstrating the association between ADH4 and the pathogenesis of NASH, our data suggest that ADH4 could be a potential biomarker for NASH. For molecular pathological mechanism analysis, two clusters of highly correlated annotation terms and genes in these terms were identified based on the intersection of DEGs. Then, pathways enriched with these genes were identified to construct the network. Using this network, both for the first time, amino acid catabolism is implicated to play a pivotal role and urea cycle is implicated to be involved in the development of NASH.The results of our study identified potential biomarkers and suggested possible molecular pathological mechanism of NASH. These findings provide a comprehensive and systematic understanding of the pathogenesis of NASH and may facilitate the diagnosis, prevention and treatment of NASH.
机译:非酒精性脂肪性肝炎(NASH)是非酒精性脂肪肝疾病(NAFLD)的一种严重形式。 NASH的分子病理学机制了解甚少。近来,诸如微阵列数据之类的高通量数据与生物信息学方法一起已成为鉴定生物标记物和研究疾病发病机理的有效方法。我们利用NASH肝脏特征明确的微阵列数据集,从生物信息学角度对NASH的潜在生物标志物和可能的病理机制进行了系统分析。分析了CodeLink人类全基因组生物阵列,以发现对照组和NASH患者之间的差异表达基因(DEG)。 。使用四种方法鉴定DEG,然后将通过这些方法鉴定的DEG的交集用于生物标志物预测和分子病理机理分析。对于生物标志物的预测,根据所有这些方法在不同表达方式下的意义,使用秩聚合对通过所有这些方法鉴定的DEG进行排名。酒精脱氢酶4(ADH4)表现出最高的排名,表明正常和疾病状态之间最显着的差异表达。我们的数据表明,ADH4可能是NASH的潜在生物标志物,再加上先前的报告证明了ADH4与NASH的发病机理之间的关联。对于分子病理机制分析,基于DEG的交集,确定了两个高度相关的注释术语和这些术语中的基因的簇。然后,鉴定富含这些基因的途径来构建网络。首次通过该网络,氨基酸分解代谢被认为起着关键作用,而尿素循环被暗示与NASH的发展有关。我们的研究结果确定了潜在的生物标志物并暗示了NASH的分子病理机制。这些发现为NASH的发病机理提供了全面而系统的理解,并可能有助于NASH的诊断,预防和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号